**Core Concept**
Pulmonary tuberculosis (TB) treatment involves a combination of antibiotics to eliminate the causative bacterium, Mycobacterium tuberculosis. Short-course therapy is a regimen designed to reduce the duration of treatment while maintaining its effectiveness.

**Why the Correct Answer is Right**
The optimal duration of short-course therapy for pulmonary TB is 6 months, as recommended by the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC). This duration is based on the principle of bactericidal activity, where the combination of rifampicin, isoniazid, pyrazinamide, and ethambutol (RHZE) has a synergistic effect, rapidly killing the M. tuberculosis bacteria. The 6-month duration allows for the complete elimination of the bacteria, reducing the risk of relapse and drug resistance.

**Why Each Wrong Option is Incorrect**
**Option A:** 3 months - This duration is too short to effectively eliminate M. tuberculosis, increasing the risk of relapse and drug resistance.
**Option B:** 9 months - This duration is longer than necessary, increasing the risk of adverse effects and treatment non-adherence.
**Option C:** 4.5 months - This duration is not a standard recommendation and may not provide adequate bactericidal activity to eliminate M. tuberculosis.

**Clinical Pearl / High-Yield Fact**
The 6-month duration of short-course therapy for pulmonary TB is a critical factor in achieving a successful outcome. It is essential to complete the full treatment course to prevent relapse and the development of drug-resistant TB.

**Correct Answer: C. 6 months.**